Cargando…

Macrophage activation syndrome in patients with systemic juvenile idiopathic arthritis treated with tocilizumab

Detalles Bibliográficos
Autores principales: De Benedetti, Fabrizio, Schneider, Rayfel, Weitzman, Sheila, Devlin, Clare, Daimaru, Kaori, Yokota, Shumpei, Takei, Syuji, Ravelli, Angelo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4184271/
http://dx.doi.org/10.1186/1546-0096-12-S1-P55
_version_ 1782337817058213888
author De Benedetti, Fabrizio
Schneider, Rayfel
Weitzman, Sheila
Devlin, Clare
Daimaru, Kaori
Yokota, Shumpei
Takei, Syuji
Ravelli, Angelo
author_facet De Benedetti, Fabrizio
Schneider, Rayfel
Weitzman, Sheila
Devlin, Clare
Daimaru, Kaori
Yokota, Shumpei
Takei, Syuji
Ravelli, Angelo
author_sort De Benedetti, Fabrizio
collection PubMed
description
format Online
Article
Text
id pubmed-4184271
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-41842712014-10-30 Macrophage activation syndrome in patients with systemic juvenile idiopathic arthritis treated with tocilizumab De Benedetti, Fabrizio Schneider, Rayfel Weitzman, Sheila Devlin, Clare Daimaru, Kaori Yokota, Shumpei Takei, Syuji Ravelli, Angelo Pediatr Rheumatol Online J Poster Presentation BioMed Central 2014-09-17 /pmc/articles/PMC4184271/ http://dx.doi.org/10.1186/1546-0096-12-S1-P55 Text en Copyright © 2014 De Benedetti et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/4.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Poster Presentation
De Benedetti, Fabrizio
Schneider, Rayfel
Weitzman, Sheila
Devlin, Clare
Daimaru, Kaori
Yokota, Shumpei
Takei, Syuji
Ravelli, Angelo
Macrophage activation syndrome in patients with systemic juvenile idiopathic arthritis treated with tocilizumab
title Macrophage activation syndrome in patients with systemic juvenile idiopathic arthritis treated with tocilizumab
title_full Macrophage activation syndrome in patients with systemic juvenile idiopathic arthritis treated with tocilizumab
title_fullStr Macrophage activation syndrome in patients with systemic juvenile idiopathic arthritis treated with tocilizumab
title_full_unstemmed Macrophage activation syndrome in patients with systemic juvenile idiopathic arthritis treated with tocilizumab
title_short Macrophage activation syndrome in patients with systemic juvenile idiopathic arthritis treated with tocilizumab
title_sort macrophage activation syndrome in patients with systemic juvenile idiopathic arthritis treated with tocilizumab
topic Poster Presentation
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4184271/
http://dx.doi.org/10.1186/1546-0096-12-S1-P55
work_keys_str_mv AT debenedettifabrizio macrophageactivationsyndromeinpatientswithsystemicjuvenileidiopathicarthritistreatedwithtocilizumab
AT schneiderrayfel macrophageactivationsyndromeinpatientswithsystemicjuvenileidiopathicarthritistreatedwithtocilizumab
AT weitzmansheila macrophageactivationsyndromeinpatientswithsystemicjuvenileidiopathicarthritistreatedwithtocilizumab
AT devlinclare macrophageactivationsyndromeinpatientswithsystemicjuvenileidiopathicarthritistreatedwithtocilizumab
AT daimarukaori macrophageactivationsyndromeinpatientswithsystemicjuvenileidiopathicarthritistreatedwithtocilizumab
AT yokotashumpei macrophageactivationsyndromeinpatientswithsystemicjuvenileidiopathicarthritistreatedwithtocilizumab
AT takeisyuji macrophageactivationsyndromeinpatientswithsystemicjuvenileidiopathicarthritistreatedwithtocilizumab
AT ravelliangelo macrophageactivationsyndromeinpatientswithsystemicjuvenileidiopathicarthritistreatedwithtocilizumab